HK1086492A1 - Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'- fluoroanilino)phenylacetic acid - Google Patents

Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'- fluoroanilino)phenylacetic acid

Info

Publication number
HK1086492A1
HK1086492A1 HK06106599.6A HK06106599A HK1086492A1 HK 1086492 A1 HK1086492 A1 HK 1086492A1 HK 06106599 A HK06106599 A HK 06106599A HK 1086492 A1 HK1086492 A1 HK 1086492A1
Authority
HK
Hong Kong
Prior art keywords
fluoroanilino
chloro
methyl
pharmaceutical composition
phenylacetic acid
Prior art date
Application number
HK06106599.6A
Other languages
English (en)
Inventor
Patrick Forenzo
Maha Y Khaled
Barbara Wang
Joseph Lawrence Zielinski
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32990870&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1086492(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1086492A1 publication Critical patent/HK1086492A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HK06106599.6A 2003-03-12 2006-06-08 Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'- fluoroanilino)phenylacetic acid HK1086492A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45414503P 2003-03-12 2003-03-12
PCT/EP2004/002528 WO2004080451A1 (en) 2003-03-12 2004-03-11 Pharmaceutical composition comprising 5-methyl-2-2’-(chloro-6’-fluoroanilino) phe nylacetic acid

Publications (1)

Publication Number Publication Date
HK1086492A1 true HK1086492A1 (en) 2006-09-22

Family

ID=32990870

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06106599.6A HK1086492A1 (en) 2003-03-12 2006-06-08 Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'- fluoroanilino)phenylacetic acid

Country Status (30)

Country Link
US (2) US20060094787A1 (es)
EP (1) EP1603550B1 (es)
JP (1) JP4580921B2 (es)
KR (1) KR20050109077A (es)
CN (1) CN100345536C (es)
AR (1) AR043536A1 (es)
AT (1) ATE418332T1 (es)
AU (1) AU2004218921B2 (es)
BR (1) BRPI0408270A (es)
CA (1) CA2518393A1 (es)
CL (1) CL2004000496A1 (es)
DE (1) DE602004018622D1 (es)
EC (1) ECSP055998A (es)
ES (1) ES2318277T3 (es)
HK (1) HK1086492A1 (es)
HR (1) HRP20050787A2 (es)
IL (1) IL170518A (es)
IS (1) IS2658B (es)
MA (1) MA27670A1 (es)
MX (1) MXPA05009686A (es)
MY (1) MY139455A (es)
NO (1) NO20054662L (es)
NZ (1) NZ542218A (es)
PE (1) PE20041063A1 (es)
PT (1) PT1603550E (es)
RU (1) RU2363462C2 (es)
TN (1) TNSN05222A1 (es)
TW (1) TWI327913B (es)
WO (1) WO2004080451A1 (es)
ZA (1) ZA200506750B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007508263A (ja) * 2003-10-08 2007-04-05 ノバルティス アクチエンゲゼルシャフト ５−メチル−２−（２’−クロロ−６’−フルオロアニリノ）フェニル酢酸を含む薬学的組成物
KR100900915B1 (ko) * 2007-05-07 2009-06-05 이연제약주식회사 메게스트롤 아세테이트를 함유하는 현탁액 제제 및 이의제조방법
EP2316422A1 (en) * 2007-11-12 2011-05-04 Novartis AG Liquid compositions comprising valsartan
EP2926810A1 (en) * 2014-03-31 2015-10-07 Sanovel Ilac Sanayi ve Ticaret A.S. Oral liquid pharmaceutical formulations of loxoprofen
CN109906079B (zh) * 2016-06-16 2022-09-30 库蒂斯制药公司 用于质子泵抑制剂混悬剂的组合物和方法
WO2018049184A1 (en) * 2016-09-09 2018-03-15 Cutispharma, Inc. Suspensions and diluents for metronidazole and baclofen
EP3655418A4 (en) 2017-06-22 2021-05-19 Triact Therapeutics, Inc. METHOD OF TREATMENT OF GLIOBLASTOMA
EP3687501A4 (en) 2017-09-29 2021-06-23 Triact Therapeutics, Inc. INIPARIB FORMS AND USES THEREOF
US11633478B2 (en) 2019-07-16 2023-04-25 Azurity Pharmaceuticals, Inc. Compositions and kits for Omeprazole suspension
US10751333B1 (en) * 2019-07-16 2020-08-25 Cutispharma, Inc. Compositions and kits for omeprazole suspension

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112604A (en) * 1989-09-01 1992-05-12 Riker Laboratories, Inc. Oral suspension formulation
US5840768A (en) * 1997-06-04 1998-11-24 Fmc Corporation MCC: alginate pharmaceutical suspensions
US6103260A (en) * 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
CO4960662A1 (es) * 1997-08-28 2000-09-25 Novartis Ag Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
US20020028794A1 (en) * 2000-07-21 2002-03-07 Brubaker Greg Allen Megestrol acetate suspension
PE20020351A1 (es) * 2000-09-11 2002-06-14 Novartis Ag Composiciones farmaceuticas que comprenden acido 5-metil-2-(2'-cloro-6'-fluoroanilino)fenilacetico como inhibidor de la ciclooxigenasa-2
MXPA04006608A (es) * 2002-01-07 2004-10-04 Pharmacia Corp Tratamiento de dolor, inflamacion y trastornos relacionados con inflamacion con una combinacion de inhibidor selectivo de ciclooxigenasa-2 y aspirina.
JP2005537223A (ja) * 2002-04-05 2005-12-08 ニトロメッド，インク． 酸化窒素供与体、組成物および使用法

Also Published As

Publication number Publication date
HRP20050787A2 (en) 2006-12-31
IS2658B (is) 2010-08-15
IS8049A (is) 2005-09-28
KR20050109077A (ko) 2005-11-17
ES2318277T3 (es) 2009-05-01
ATE418332T1 (de) 2009-01-15
DE602004018622D1 (de) 2009-02-05
EP1603550B1 (en) 2008-12-24
ECSP055998A (es) 2006-01-27
IL170518A (en) 2010-11-30
TW200505429A (en) 2005-02-16
NO20054662L (no) 2005-12-05
AR043536A1 (es) 2005-08-03
TNSN05222A1 (en) 2007-06-11
NZ542218A (en) 2009-01-31
RU2363462C2 (ru) 2009-08-10
JP4580921B2 (ja) 2010-11-17
US20060094787A1 (en) 2006-05-04
CN1756541A (zh) 2006-04-05
US20090048344A1 (en) 2009-02-19
WO2004080451A1 (en) 2004-09-23
CL2004000496A1 (es) 2005-01-14
AU2004218921A1 (en) 2004-09-23
MY139455A (en) 2009-10-30
MA27670A1 (fr) 2005-12-01
NO20054662D0 (no) 2005-10-11
PE20041063A1 (es) 2005-03-07
CN100345536C (zh) 2007-10-31
TWI327913B (en) 2010-08-01
EP1603550A1 (en) 2005-12-14
MXPA05009686A (es) 2005-10-20
CA2518393A1 (en) 2004-09-23
PT1603550E (pt) 2009-03-20
AU2004218921B2 (en) 2007-05-17
BRPI0408270A (pt) 2006-03-07
JP2006519811A (ja) 2006-08-31
ZA200506750B (en) 2007-02-28
RU2005131310A (ru) 2006-05-10

Similar Documents

Publication Publication Date Title
HK1086492A1 (en) Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'- fluoroanilino)phenylacetic acid
IL173808A0 (en) Pharmaceutical liposomal formulations
IL173726A (en) Pharmaceutical compositions containing n-n-dihaloamino acids and their uses
GB0210397D0 (en) Pharmaceutical formulations
ZA200604352B (en) Azepinondole derivatives as pharmaceutical agents
IL170758A0 (en) 7-amino-isoindolyl compounds and their pharmaceutical uses
IL172824A0 (en) Pharmaceutical formulations
GB0302671D0 (en) Pharmaceutical formulations
EP1603593A4 (en) PHARMACEUTICAL COMPOSITION
ITMI20031570A1 (it) Composizione per uso dietetico, farmaceutico o cosmetico
EP1425019A4 (en) PHARMACEUTICAL COMPOSITION
IL172814A0 (en) Novel solid pharmaceutical composition comprising amisulpride
AU2003250372A8 (en) Pharmaceutical composition
HK1090356A1 (en) 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
GB2392093B (en) Pharmaceutical formulations
GB0316341D0 (en) Pharmaceutical formulations
GB0317877D0 (en) Pharmaceutical combinations and formulations with improved stability
AU2003245774A1 (en) Pharmaceutical dosage form bearing pregnancy-friendly indicia
HK1094676A1 (en) Solid pharmaceutical preparation form
SI1653963T1 (sl) Farmacevtski sestavek piribedila za nazalno aplikacijo
GB0316335D0 (en) Pharmaceutical formulations
IL175282A0 (en) Preparation of pharmaceutical salts of [1,4]-bipiperidine
IL164994A0 (en) Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof
GB0219421D0 (en) Improvements in or relating to formulations for the delivery of drugs
GB0324912D0 (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130311